SEI Investments’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

SEI Investments’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-106,270	Closed	-$712K	–	2726
2022 Q3	$712K	Sell	106,270 -3,326	-3%	-$20.2K	﹤0.01%	1938
2022 Q2	$461K	Buy	+109,596	New	+$434K	﹤0.01%	2136
2019 Q1	–	Sell	-2,266	Closed	-$24K	–	3007
2018 Q4	$24K	Buy	2,266 +541	+31%	+$7.47K	﹤0.01%	2476
2018 Q3	$21K	Sell	1,725 -3,452	-67%	-$54.3K	﹤0.01%	2377
2018 Q2	$87K	Buy	5,177 +1,989	+62%	+$38.6K	﹤0.01%	2327
2018 Q1	$73K	Buy	3,188 +2,331	+272%	+$51.8K	﹤0.01%	2236
2017 Q4	$22K	Buy	+857	New	+$17.3K	﹤0.01%	2581

Other funds holding CNCE

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SEI Investments's CNCE Position: Q4 2022 in Review

SEI Investments sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q4 2022, closing a stake of 106,270 shares — an estimated $712K sold.

SEI Investments first reported a position in CNCE in Q4 2017 and held it in 7 quarters. The position peaked at $712K in Q3 2022. 85 funds tracked by Wall St. Rank hold CNCE as of Q4 2022.

SEI Investments reported no remaining Concert Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
SEI Investments sold 106,270 Concert Pharmaceuticals, Inc. shares in Q4 2022, an estimated $712K.
SEI Investments first reported a position in Concert Pharmaceuticals, Inc. in Q4 2017 and held it in 7 quarters.
SEI Investments's Concert Pharmaceuticals, Inc. position peaked at $712K in Q3 2022.
85 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q4 2022.

Based on SEI Investments's 13F filing for Q4 2022, filed 10 Feb 2023.